Hypermethylation-mediated partial transcriptional silencing of DAP-kinase gene in bladder cancer

Biomarkers

Volumn 15, Issue 2, 2010, Pages 167-174

  Sobti, Ranbir Chander ^a   MalekZadeh, Kianoosh ^a   Nikbakht, Mohsen ^a   Sadeghi, Irandokht Asadi ^b   Shekari, Mohammad ^a   Singh, Shrawan Kumar ^c  

^a PANJAB UNIVERSITY   (India)

^b Zabol Medical University   (Iran)

^c POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Bladder cancer; DAP kinase; Hypermethylation

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; MESSENGER RNA;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER RISK; CELL TRANSFORMATION; CIGARETTE SMOKING; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; PROTEIN METHYLATION; SMOKING HABIT; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CARCINOMA, TRANSITIONAL CELL; DNA METHYLATION; FEMALE; GENE SILENCING; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RNA, MESSENGER; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 77249117869     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/13547500903395124     Document Type: Article

References (22)

1. Baylin SB, Herman JG. (2000). DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16:168-74.
2. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. (1998). Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72:141-6.
3. Catto JW, Azzouzi AR, Rehman I, et al. (2005). Promoter hypermethylation is associated with tumour location, stage, and subsequent progression in transitional cell carcinoma. J Clin Oncol 23:2903-10.
4. Chan MW, Chan LW, Tang NL, Lo KW, Lee TL, Cheung HY, et al. (2002). Hypermethylation of multiple genes in tumour tissues and voided urine in urinary bladder cancer patients. Clin Cancer Res 8:464-70.
5. Christoph F, Weikert S, Kempkensteffen C, Krause H, Schostak M, Miller K, Schrader M. (2006). Regularly methylated novel proapoptotic genes associated with recurrence in transitional cell carcinoma of the bladder. Int J Cancer 119:1396-402.
6. Cohen O, Feinstein E, Kimchi A. (1997). DAP-kinase is a Ca2+/ calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J 16:998-1004.
7. Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi A. (1995). Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Dev 9:15-21.
8. Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG. (1998). Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res. 58:4515-18.
9. Esteller M, Corn PG, Baylin SB, Herman JG. (2001). A gene hypermethylation profile of human cancer. Cancer Res 61:3225-9.
10. Friedrich MG, Weisenberger DJ, Cheng JC, et al. (2004). Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clin Cancer Res 10:7457-65.
11. IARC. (2002). Cancer Incidence, Mortality and Prevalence Worldwide (2002 estimates). Available at: http://www.dep.IARC.fr/globocan/database.htm [accessed 2007].
12. Gonzalez-Gomez P, Bello MJ, Arjona D, Alonso ME, Lomas J, de Campos JM, et al. (2003). Aberrant CpG island methylation in neurofibromas and neurofibrosarcomas. Oncol Rep 10:1519-23.
13. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands (DNA methylation/tumour suppressor genes/pl6/p15). Proc Natl Acad Sci USA 93:9821-6.
14. Inbal B, Cohen O, Polak-Charcon S, Kopolovic J, Vadai E, Eisenbach L, Kimchi A. (1997). DAP-kinase links the control of apoptosis to metastasis. Nature 390:180-5.
15. Katzenellenbogen RA, Baylin SB, Herman JG. (1999). Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood 93:4347-53.
16. Kissil JL, Feinstein E, Cohen O, Jones PA, Tsai YC, Knowles MA, Eydmann ME, Kimchi A. (1997). DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumour suppressor gene. Oncogene 15:403-11.
17. Maruyama R, Toyooka S, Toyooka KO, et al. (2001). Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res 61:8659-63.
18. Merlo A, Herman JG, Mao L, et al. (1995). 5-CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1:686-92.
19. Mitra AP, Datar RH, Cote RJ. (2006). Molecular Pathways in Invasive Bladder Cancer: New Insights into Mechanisms, Progression, and Target Identification. J. Clin. Oncol. 24: 5552-64.
20. Mishina D, Katsel P, Brown ST, Gilberts ECAM, Greenstein RJ. (1996). On the etiology of Crohn disease. Proc Natl Acad Sci USA 93:9816-20.
21. Raveh T, Droguett G, Horwitz MS, DePinho RA, Kimchi A. (2001). DAP-kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat Cell Biol 3:1-7.
22. Yates DR, Rehman I, Meuth M, et al. (2006). Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls. Oncogene 25:1984-8.